Ask AI
Obesity QI: Prior Authorizations for AOMs
Quality Improvement in Obesity Care: How to Manage Prior Authorizations for Antiobesity Agents

Released: June 27, 2025

Expiration: June 26, 2026

Activity

Progress
1
Course Completed

References

  1. Tirzepatide [prescribing information]. Indianapolis, IN: Eli Lilly and Company; 2024.
  2. Semaglutide [prescribing information]. Plainsboro, NJ: Novo Nordisk Inc.; 2022.